Disclosures for "Demographics and Clinical Factors Associated with Persistence on Cannabidiol in US Patients with Lennox-Gastaut Syndrome (LGS), Dravet Syndrome (DS), Tuberous Sclerosis Complex (TSC), or Other Refractory Epilepsies"
-
Dr. Burn has nothing to disclose.
-
Dr. Osborne has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Dr. Osborne has stock in Jazz Pharmaceuticals.
-
Dr. Sillah has nothing to disclose.
-
Dr. Saurer has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Dr. Saurer has stock in Jazz Pharmaceuticals.
-
Dr. Faithe has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Dr. Faithe has stock in Jazz Pharmaceuticals. Dr. Faithe has stock in Amgen .
-
Dr. McCarter has nothing to disclose.
-
Dr. Shah has received personal compensation for serving as an employee of Jazz Pharmaceuticals. An immediate family member of Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Madrigal Pharmaceuticals. The institution of an immediate family member of Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Madrigal Pharmaceuticals. Dr. Shah has stock in Jazz Pharmaceuticals.
-
Dr. BARNES has nothing to disclose.
-
Miss Sachdev has nothing to disclose.
-
Mr. GUPTA has nothing to disclose.
-
Author has nothing to disclose